Our findings link HDAC1 and OGG1 to oxidative DNA damage, neuronal gene expression, synaptic plasticity, and cognitive performance in brain aging and neurodegenerative disease, and highlight the therapeutic potential of pharmacological HDAC1 activation in aging and neurological disorders. This evidence concerns the gene HDAC1 and nervous system disorder.